Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Clinical trial NCT01161264 · COMPLETED

Trial details

NCT number: NCT01161264
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2010-07-01
Primary completion: 2010-07-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.